Your browser doesn't support javascript.
loading
Anti-BRAF/anti-MEK targeted therapies for metastatic melanoma patients during the COVID-19 outbreak: experience from an Italian skin cancer unit.
Quaglino, Pietro; Fava, Paolo; Brizio, Matteo; Marra, Elena; Rubatto, Marco; Merli, Martina; Tonella, Luca; Ribero, Simone; Fierro, Maria Teresa.
  • Quaglino P; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Fava P; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Brizio M; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Marra E; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Rubatto M; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Merli M; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Tonella L; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Ribero S; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
  • Fierro MT; Dermatology Clinic, University of Turin, Turin, 10124, Italy.
Future Oncol ; 17(7): 759-761, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33533662

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Quinasas de Proteína Quinasa Activadas por Mitógenos / Proteínas Proto-Oncogénicas B-raf / SARS-CoV-2 / COVID-19 / Melanoma Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Quinasas de Proteína Quinasa Activadas por Mitógenos / Proteínas Proto-Oncogénicas B-raf / SARS-CoV-2 / COVID-19 / Melanoma Límite: Humans Idioma: En Año: 2021 Tipo del documento: Article